Global Transforming Growth Factor Beta 1 Market Insights And Forecast To 2028

1 Study Coverage
1.1 Transforming Growth Factor Beta 1 Product Introduction
1.2 Market by Type
1.2.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transforming Growth Factor Beta 1 Sales Estimates and Forecasts 2017-2028
2.2 Global Transforming Growth Factor Beta 1 Revenue Estimates and Forecasts 2017-2028
2.3 Global Transforming Growth Factor Beta 1 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Transforming Growth Factor Beta 1 Sales by Region
2.4.1 Global Transforming Growth Factor Beta 1 Sales by Region (2017-2022)
2.4.2 Global Sales Transforming Growth Factor Beta 1 by Region (2023-2028)
2.5 Global Transforming Growth Factor Beta 1 Revenue by Region
2.5.1 Global Transforming Growth Factor Beta 1 Revenue by Region (2017-2022)
2.5.2 Global Transforming Growth Factor Beta 1 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Transforming Growth Factor Beta 1 Sales by Manufacturers
3.1.1 Global Top Transforming Growth Factor Beta 1 Manufacturers by Sales (2017-2022)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transforming Growth Factor Beta 1 in 2021
3.2 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (2017-2022)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Transforming Growth Factor Beta 1 Revenue in 2021
3.3 Global Transforming Growth Factor Beta 1 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Transforming Growth Factor Beta 1 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transforming Growth Factor Beta 1 Sales by Type
4.1.1 Global Transforming Growth Factor Beta 1 Historical Sales by Type (2017-2022)
4.1.2 Global Transforming Growth Factor Beta 1 Forecasted Sales by Type (2023-2028)
4.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
4.2 Global Transforming Growth Factor Beta 1 Revenue by Type
4.2.1 Global Transforming Growth Factor Beta 1 Historical Revenue by Type (2017-2022)
4.2.2 Global Transforming Growth Factor Beta 1 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
4.3 Global Transforming Growth Factor Beta 1 Price by Type
4.3.1 Global Transforming Growth Factor Beta 1 Price by Type (2017-2022)
4.3.2 Global Transforming Growth Factor Beta 1 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Transforming Growth Factor Beta 1 Sales by Application
5.1.1 Global Transforming Growth Factor Beta 1 Historical Sales by Application (2017-2022)
5.1.2 Global Transforming Growth Factor Beta 1 Forecasted Sales by Application (2023-2028)
5.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
5.2 Global Transforming Growth Factor Beta 1 Revenue by Application
5.2.1 Global Transforming Growth Factor Beta 1 Historical Revenue by Application (2017-2022)
5.2.2 Global Transforming Growth Factor Beta 1 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
5.3 Global Transforming Growth Factor Beta 1 Price by Application
5.3.1 Global Transforming Growth Factor Beta 1 Price by Application (2017-2022)
5.3.2 Global Transforming Growth Factor Beta 1 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Transforming Growth Factor Beta 1 Market Size by Type
6.1.1 North America Transforming Growth Factor Beta 1 Sales by Type (2017-2028)
6.1.2 North America Transforming Growth Factor Beta 1 Revenue by Type (2017-2028)
6.2 North America Transforming Growth Factor Beta 1 Market Size by Application
6.2.1 North America Transforming Growth Factor Beta 1 Sales by Application (2017-2028)
6.2.2 North America Transforming Growth Factor Beta 1 Revenue by Application (2017-2028)
6.3 North America Transforming Growth Factor Beta 1 Market Size by Country
6.3.1 North America Transforming Growth Factor Beta 1 Sales by Country (2017-2028)
6.3.2 North America Transforming Growth Factor Beta 1 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Transforming Growth Factor Beta 1 Market Size by Type
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Type (2017-2028)
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Type (2017-2028)
7.2 Europe Transforming Growth Factor Beta 1 Market Size by Application
7.2.1 Europe Transforming Growth Factor Beta 1 Sales by Application (2017-2028)
7.2.2 Europe Transforming Growth Factor Beta 1 Revenue by Application (2017-2028)
7.3 Europe Transforming Growth Factor Beta 1 Market Size by Country
7.3.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2028)
7.3.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Type
8.1.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Type (2017-2028)
8.1.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Type (2017-2028)
8.2 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Application
8.2.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Application (2017-2028)
8.2.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Application (2017-2028)
8.3 Asia Pacific Transforming Growth Factor Beta 1 Market Size by Region
8.3.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2017-2028)
8.3.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Transforming Growth Factor Beta 1 Market Size by Type
9.1.1 Latin America Transforming Growth Factor Beta 1 Sales by Type (2017-2028)
9.1.2 Latin America Transforming Growth Factor Beta 1 Revenue by Type (2017-2028)
9.2 Latin America Transforming Growth Factor Beta 1 Market Size by Application
9.2.1 Latin America Transforming Growth Factor Beta 1 Sales by Application (2017-2028)
9.2.2 Latin America Transforming Growth Factor Beta 1 Revenue by Application (2017-2028)
9.3 Latin America Transforming Growth Factor Beta 1 Market Size by Country
9.3.1 Latin America Transforming Growth Factor Beta 1 Sales by Country (2017-2028)
9.3.2 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Type
10.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Type (2017-2028)
10.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Application
10.2.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Application (2017-2028)
10.3 Middle East and Africa Transforming Growth Factor Beta 1 Market Size by Country
10.3.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Shionogi Ltd
11.2.1 Shionogi Ltd Corporation Information
11.2.2 Shionogi Ltd Overview
11.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Shionogi Ltd Recent Developments
11.3 Acceleron Pharma Inc
11.3.1 Acceleron Pharma Inc Corporation Information
11.3.2 Acceleron Pharma Inc Overview
11.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Acceleron Pharma Inc Recent Developments
11.4 Genzyme Corp
11.4.1 Genzyme Corp Corporation Information
11.4.2 Genzyme Corp Overview
11.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genzyme Corp Recent Developments
11.5 Isarna Therapeutics GmbH
11.5.1 Isarna Therapeutics GmbH Corporation Information
11.5.2 Isarna Therapeutics GmbH Overview
11.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Isarna Therapeutics GmbH Recent Developments
11.6 Scholar Rock
11.6.1 Scholar Rock Corporation Information
11.6.2 Scholar Rock Overview
11.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Scholar Rock Recent Developments
11.7 Sirnaomics Inc
11.7.1 Sirnaomics Inc Corporation Information
11.7.2 Sirnaomics Inc Overview
11.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sirnaomics Inc Recent Developments
11.8 Eli Lilly and Co
11.8.1 Eli Lilly and Co Corporation Information
11.8.2 Eli Lilly and Co Overview
11.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly and Co Recent Developments
11.9 Formation Biologics Inc
11.9.1 Formation Biologics Inc Corporation Information
11.9.2 Formation Biologics Inc Overview
11.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Formation Biologics Inc Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transforming Growth Factor Beta 1 Industry Chain Analysis
12.2 Transforming Growth Factor Beta 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transforming Growth Factor Beta 1 Production Mode & Process
12.4 Transforming Growth Factor Beta 1 Sales and Marketing
12.4.1 Transforming Growth Factor Beta 1 Sales Channels
12.4.2 Transforming Growth Factor Beta 1 Distributors
12.5 Transforming Growth Factor Beta 1 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Transforming Growth Factor Beta 1 Industry Trends
13.2 Transforming Growth Factor Beta 1 Market Drivers
13.3 Transforming Growth Factor Beta 1 Market Challenges
13.4 Transforming Growth Factor Beta 1 Market Restraints
14 Key Findings in The Global Transforming Growth Factor Beta 1 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pirfenidone
Table 3. Major Manufacturers of Galunisertib
Table 4. Major Manufacturers of Others
Table 5. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Transforming Growth Factor Beta 1 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Transforming Growth Factor Beta 1 Sales by Region (2017-2022) & (K Units)
Table 8. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2017-2022)
Table 9. Global Transforming Growth Factor Beta 1 Sales by Region (2023-2028) & (K Units)
Table 10. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2023-2028)
Table 11. Global Transforming Growth Factor Beta 1 Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2017-2022)
Table 13. Global Transforming Growth Factor Beta 1 Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2023-2028)
Table 15. Global Transforming Growth Factor Beta 1 Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturers (2017-2022)
Table 17. Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2017-2022)
Table 19. Transforming Growth Factor Beta 1 Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Transforming Growth Factor Beta 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transforming Growth Factor Beta 1 as of 2021)
Table 22. Transforming Growth Factor Beta 1 Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Transforming Growth Factor Beta 1 Product Offered
Table 24. Date of Manufacturers Enter into Transforming Growth Factor Beta 1 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 27. Global Transforming Growth Factor Beta 1 Sales by Type (2023-2028) & (K Units)
Table 28. Global Transforming Growth Factor Beta 1 Sales Share by Type (2017-2022)
Table 29. Global Transforming Growth Factor Beta 1 Sales Share by Type (2023-2028)
Table 30. Global Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Transforming Growth Factor Beta 1 Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Transforming Growth Factor Beta 1 Revenue Share by Type (2017-2022)
Table 33. Global Transforming Growth Factor Beta 1 Revenue Share by Type (2023-2028)
Table 34. Transforming Growth Factor Beta 1 Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Transforming Growth Factor Beta 1 Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 37. Global Transforming Growth Factor Beta 1 Sales by Application (2023-2028) & (K Units)
Table 38. Global Transforming Growth Factor Beta 1 Sales Share by Application (2017-2022)
Table 39. Global Transforming Growth Factor Beta 1 Sales Share by Application (2023-2028)
Table 40. Global Transforming Growth Factor Beta 1 Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Transforming Growth Factor Beta 1 Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Transforming Growth Factor Beta 1 Revenue Share by Application (2017-2022)
Table 43. Global Transforming Growth Factor Beta 1 Revenue Share by Application (2023-2028)
Table 44. Transforming Growth Factor Beta 1 Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Transforming Growth Factor Beta 1 Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 47. North America Transforming Growth Factor Beta 1 Sales by Type (2023-2028) & (K Units)
Table 48. North America Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Transforming Growth Factor Beta 1 Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 51. North America Transforming Growth Factor Beta 1 Sales by Application (2023-2028) & (K Units)
Table 52. North America Transforming Growth Factor Beta 1 Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Transforming Growth Factor Beta 1 Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 55. North America Transforming Growth Factor Beta 1 Sales by Country (2023-2028) & (K Units)
Table 56. North America Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Transforming Growth Factor Beta 1 Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 59. Europe Transforming Growth Factor Beta 1 Sales by Type (2023-2028) & (K Units)
Table 60. Europe Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Transforming Growth Factor Beta 1 Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 63. Europe Transforming Growth Factor Beta 1 Sales by Application (2023-2028) & (K Units)
Table 64. Europe Transforming Growth Factor Beta 1 Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Transforming Growth Factor Beta 1 Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 67. Europe Transforming Growth Factor Beta 1 Sales by Country (2023-2028) & (K Units)
Table 68. Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Transforming Growth Factor Beta 1 Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Transforming Growth Factor Beta 1 Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Transforming Growth Factor Beta 1 Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Transforming Growth Factor Beta 1 Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Transforming Growth Factor Beta 1 Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Transforming Growth Factor Beta 1 Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Transforming Growth Factor Beta 1 Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Transforming Growth Factor Beta 1 Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Transforming Growth Factor Beta 1 Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2023-2028) & (US$ Million)
Table 106. Roche Corporation Information
Table 107. Roche Description and Major Businesses
Table 108. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Roche Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Roche Recent Developments
Table 111. Shionogi Ltd Corporation Information
Table 112. Shionogi Ltd Description and Major Businesses
Table 113. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Shionogi Ltd Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Shionogi Ltd Recent Developments
Table 116. Acceleron Pharma Inc Corporation Information
Table 117. Acceleron Pharma Inc Description and Major Businesses
Table 118. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Acceleron Pharma Inc Recent Developments
Table 121. Genzyme Corp Corporation Information
Table 122. Genzyme Corp Description and Major Businesses
Table 123. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Genzyme Corp Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Genzyme Corp Recent Developments
Table 126. Isarna Therapeutics GmbH Corporation Information
Table 127. Isarna Therapeutics GmbH Description and Major Businesses
Table 128. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Isarna Therapeutics GmbH Recent Developments
Table 131. Scholar Rock Corporation Information
Table 132. Scholar Rock Description and Major Businesses
Table 133. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Scholar Rock Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Scholar Rock Recent Developments
Table 136. Sirnaomics Inc Corporation Information
Table 137. Sirnaomics Inc Description and Major Businesses
Table 138. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Sirnaomics Inc Recent Developments
Table 141. Eli Lilly and Co Corporation Information
Table 142. Eli Lilly and Co Description and Major Businesses
Table 143. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Eli Lilly and Co Recent Developments
Table 146. Formation Biologics Inc Corporation Information
Table 147. Formation Biologics Inc Description and Major Businesses
Table 148. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Formation Biologics Inc Recent Developments
Table 151. Novartis AG Corporation Information
Table 152. Novartis AG Description and Major Businesses
Table 153. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. Novartis AG Transforming Growth Factor Beta 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Novartis AG Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Transforming Growth Factor Beta 1 Distributors List
Table 159. Transforming Growth Factor Beta 1 Customers List
Table 160. Transforming Growth Factor Beta 1 Market Trends
Table 161. Transforming Growth Factor Beta 1 Market Drivers
Table 162. Transforming Growth Factor Beta 1 Market Challenges
Table 163. Transforming Growth Factor Beta 1 Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Transforming Growth Factor Beta 1 Product Picture
Figure 3. Global Transforming Growth Factor Beta 1 Market Share by Type in 2021 & 2028
Figure 3. Pirfenidone Product Picture
Figure 4. Galunisertib Product Picture
Figure 5. Others Product Picture
Figure 6. Global Transforming Growth Factor Beta 1 Market Share by Application in 2021 & 2028
Figure 7. IPF
Figure 8. Cancer
Figure 9. Others
Figure 10. Transforming Growth Factor Beta 1 Report Years Considered
Figure 11. Global Transforming Growth Factor Beta 1 Sales 2017-2028 (K Units)
Figure 12. Global Transforming Growth Factor Beta 1 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Transforming Growth Factor Beta 1 Revenue 2017-2028 (US$ Million)
Figure 14. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2017-2022)
Figure 16. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2023-2028)
Figure 17. North America Transforming Growth Factor Beta 1 Sales YoY (2017-2028) & (K Units)
Figure 18. North America Transforming Growth Factor Beta 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Transforming Growth Factor Beta 1 Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Transforming Growth Factor Beta 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Transforming Growth Factor Beta 1 Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Transforming Growth Factor Beta 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Transforming Growth Factor Beta 1 Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Transforming Growth Factor Beta 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Transforming Growth Factor Beta 1 Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Transforming Growth Factor Beta 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Transforming Growth Factor Beta 1 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Transforming Growth Factor Beta 1 in the World: Market Share by Transforming Growth Factor Beta 1 Revenue in 2021
Figure 29. Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
Figure 31. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
Figure 32. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
Figure 33. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
Figure 34. North America Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
Figure 35. North America Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
Figure 36. North America Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
Figure 37. North America Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
Figure 38. North America Transforming Growth Factor Beta 1 Sales Share by Country (2017-2028)
Figure 39. North America Transforming Growth Factor Beta 1 Revenue Share by Country (2017-2028)
Figure 40. U.S. Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
Figure 43. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
Figure 44. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
Figure 45. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
Figure 46. Europe Transforming Growth Factor Beta 1 Sales Share by Country (2017-2028)
Figure 47. Europe Transforming Growth Factor Beta 1 Revenue Share by Country (2017-2028)
Figure 48. Germany Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 49. France Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Transforming Growth Factor Beta 1 Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Transforming Growth Factor Beta 1 Revenue Share by Region (2017-2028)
Figure 59. China Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 62. India Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
Figure 69. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
Figure 71. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Transforming Growth Factor Beta 1 Sales Share by Country (2017-2028)
Figure 73. Latin America Transforming Growth Factor Beta 1 Revenue Share by Country (2017-2028)
Figure 74. Mexico Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Transforming Growth Factor Beta 1 Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Share by Country (2017-2028)
Figure 83. Turkey Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Transforming Growth Factor Beta 1 Revenue (2017-2028) & (US$ Million)
Figure 86. Transforming Growth Factor Beta 1 Value Chain
Figure 87. Transforming Growth Factor Beta 1 Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.